Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors

Brain metastases are a devastating sequela of common primary cancers (e.g., lung, breast, and skin) and have limited effective therapeutic options. Previously, systemic chemotherapy failed to demonstrate significant benefit in patients with brain metastases, but in recent decades, targeted therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsui, Jennifer K., Perlow, Haley K., Raj, Rohit K., Nalin, Ansel P., Lehrer, Eric J., Kotecha, Rupesh, Trifiletti, Daniel M., McClelland, Shearwood, Kendra, Kari, Williams, Nicole, Owen, Dwight H., Presley, Carolyn J., Thomas, Evan M., Beyer, Sasha J., Blakaj, Dukagjin M., Ahluwalia, Manmeet S., Raval, Raju R., Palmer, Joshua D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496359/
https://www.ncbi.nlm.nih.gov/pubmed/36140312
http://dx.doi.org/10.3390/biomedicines10092211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496359/
https://www.ncbi.nlm.nih.gov/pubmed/36140312
http://dx.doi.org/10.3390/biomedicines10092211

Ejemplares similares